If you pay attention to the biofuels efforts in the Bay Area or read online science magazines such as Wired or New Scientist, it’s likely you’ve heard of Synthetic Biology. More of a movement than a field, Synthetic Biology envisions biology as an engineering discipline waiting to happen. Essentially, Synthetic Biology aims to circumvent or control the complexities in biology in order to build novel, effective biological systems reliably and quickly for such applications as diesel production and tumor killing bacteria. For example, imagine you want to engineer yeast to make red beer that tastes like lemon. Synthetic biology would have you pick up a “red” gene and a “lemon” gene, plug them into the yeast in a standardized, programmed way, and presto: Red lemon hefeweizen! Unfortunately, the realities of biology require much more than that. In reality, biology is so complex, few things we do ever work as expected or intended. Because of this, most synthetic biology projects quickly run into difficulty and often take years to hack together. But this hasn’t stopped synthetic biologists from making broad claims about the potential of their approaches. It’s been said that cheap biofuels, cures for diseases, and fantastic new biotechnologies are in the pipeline. Recently, however, Synthetic Biologists are encountering resistance as reality has begun to catch up to the hype.
A recent news feature in Nature Biotechnology asked some of the most prominent synthetic biologists how they define their field. The diversity and vagueness of the responses highlighted the difficulties the community has had centering itself on a set of focused objectives. Because Synthetic Biology is such a new field with no central discovery to mark its launch point, and because the application of systematic engineering to biology is so fraught with problems, the Synthetic Biology community has had trouble defining itself in concrete terms. This comes despite such efforts as the Synthetic Biology Engineering Research Center (SynBERC), an NSF-funded consortium of faculty across various universities that is intended to facilitate joint research efforts within Synthetic Biology. Some responses in the article suggested that Synthetic Biology had become more of a buzzword meant to garner federal research dollars than a productive field. For those of us in the field at the moment, this hit painfully close to home. Read the rest of this entry »



















